Earnings Call · Q2 FY2023·2023-08-04

Q2 23EPS +17.20%·Rev n/aQ1 23EPS +20.39%·Rev n/aQ4 22EPS +3.74%·Rev n/aQ3 22EPS -8.57%·Rev n/a⚠ consensus missing

Travere Therapeutics, Inc. TVTX

Naomi Eichenbaum — Vice President of Investor Relations

Eric Dube — Chief Executive Officer

Jula Inrig — Chief Medical Officer

Peter Heerma — President and Chief Commercial Officer

Chris Cline — Chief Financial Officer

−4.7%1d on move date−4.2% vs SPY3d−4.8%5d−3.7%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more TVTX calls or request research access.

More TVTX calls Browse calls Request research access